TYPE II COLLAGEN GENE MUTATIONS IN OSTEOARTHRITIS

骨关节炎中的 II 型胶原蛋白基因突变

基本信息

  • 批准号:
    2081206
  • 负责人:
  • 金额:
    $ 17.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1994
  • 资助国家:
    美国
  • 起止时间:
    1994-08-15 至 1997-06-30
  • 项目状态:
    已结题

项目摘要

The etiology of osteoarthritis (OA), is at present unknown. Genetic, environmental, metabolic and biomechanical factors have been suggested as playing possible roles.Interest in a genetic role for the etiology of OA has expanded based on clinical identification of positive inheritance patterns in certain disease sub-sets such as Heberden's nodes, differences in the prevalence of OA among different races and populations, increased frequency of OA in patients with HLA-A1B8 and HLA- B8 and the recent demonstration of a type-II collagen gene (COL2A1) mutation as a cause of primary generalized OA in at least one form of the disease, primary OA associated with a spinal chondrodysplasia. The mutation resulted in the replacement of arginine at position 519 of the a1(II) collagen molecule to cysteine, an amino acid not found in type-II collagen from humans or other species studied so far. Further studies in our laboratory have demonstrated the a1-519 mutation in an additional two of seven families studied. The studies proposed in this proposal will: (1) determine the prevalence of the a-519 mutation with strong family clustering of generalized OA and in non-related individuals with hip/knee OA; and identify other mutations in the COL2A1 gene; and (2) study body fluid biochemical markers of cartilage (collagen, proteoglycan) metabolism to assess OA etiopathologic mechanisms and clinical utility. The results of these studies will allow us to develop DNA probes; to delineate disease susceptibility of individuals to OA; and to correlate various gene defects with varying phenotypic patterns of disease severity. Assessment of biochemical markers of cartilage will add to our understanding of OA disease mechanisms.
骨关节炎(OA)的病因目前尚不清楚。遗传的,

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROLAND W MOSKOWITZ其他文献

ROLAND W MOSKOWITZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROLAND W MOSKOWITZ', 18)}}的其他基金

GENETIC MUTATIONS AS ETIOLOGIC FACTORS IN OSTEOARTHRITIS
基因突变作为骨关节炎的病因
  • 批准号:
    6632671
  • 财政年份:
    2001
  • 资助金额:
    $ 17.57万
  • 项目类别:
GENETIC MUTATIONS AS ETIOLOGIC FACTORS IN OSTEOARTHRITIS
基因突变作为骨关节炎的病因
  • 批准号:
    6758067
  • 财政年份:
    2001
  • 资助金额:
    $ 17.57万
  • 项目类别:
GENETIC MUTATIONS AS ETIOLOGIC FACTORS IN OSTEOARTHRITIS
基因突变作为骨关节炎的病因
  • 批准号:
    6511988
  • 财政年份:
    2001
  • 资助金额:
    $ 17.57万
  • 项目类别:
GENETIC MUTATIONS AS ETIOLOGIC FACTORS IN OSTEOARTHRITIS
基因突变作为骨关节炎的病因
  • 批准号:
    6193935
  • 财政年份:
    2001
  • 资助金额:
    $ 17.57万
  • 项目类别:
TYPE II COLLAGEN GENE MUTATIONS IN OSTEOARTHRITIS
骨关节炎中的 II 型胶原蛋白基因突变
  • 批准号:
    2081207
  • 财政年份:
    1994
  • 资助金额:
    $ 17.57万
  • 项目类别:
TYPE II COLLAGEN GENE MUTATIONS IN OSTEOARTHRITIS
骨关节炎中的 II 型胶原蛋白基因突变
  • 批准号:
    2081208
  • 财政年份:
    1994
  • 资助金额:
    $ 17.57万
  • 项目类别:
PATHOGENESIS AND THERAPY OF EXPERIMENTAL OSTEOARTHRITIS
实验性骨关节炎的发病机制和治疗
  • 批准号:
    2078679
  • 财政年份:
    1993
  • 资助金额:
    $ 17.57万
  • 项目类别:
PATHOGENESIS AND THERAPY OF EXPERIMENTAL OSTEOARTHRITIS
实验性骨关节炎的发病机制和治疗
  • 批准号:
    2078680
  • 财政年份:
    1993
  • 资助金额:
    $ 17.57万
  • 项目类别:
PATHOGENESIS AND THERAPY OF EXPERIMENTAL OSTEOARTHRITIS
实验性骨关节炎的发病机制和治疗
  • 批准号:
    2078678
  • 财政年份:
    1993
  • 资助金额:
    $ 17.57万
  • 项目类别:
TRAINING PROGRAM IN MUSCULOSKELETAL RESEARCH
肌肉骨骼研究培训计划
  • 批准号:
    2077832
  • 财政年份:
    1985
  • 资助金额:
    $ 17.57万
  • 项目类别:

相似海外基金

Development of a screening diagnostic for the detection of viruses and bacteria from body fluids that utilizes the unparalleled structural characterization of mass spectrometry
利用无与伦比的质谱结构表征,开发用于检测体液中病毒和细菌的筛查诊断方法
  • 批准号:
    10728116
  • 财政年份:
    2023
  • 资助金额:
    $ 17.57万
  • 项目类别:
Metagenomic analysis of tissues and body fluids in neonatal hepatitis and encephalitis
新生儿肝炎和脑炎组织和体液的宏基因组分析
  • 批准号:
    22K19494
  • 财政年份:
    2022
  • 资助金额:
    $ 17.57万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Liquid biopsy for Rhabdoid tumor by Exoxomal-microRNAs in blood and other body fluids
利用血液和其他体液中的 Exoxomal-microRNA 对横纹肌样瘤进行液体活检
  • 批准号:
    21K07778
  • 财政年份:
    2021
  • 资助金额:
    $ 17.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
16S rRNA gene sequencing-based exploring bacterial DNA markers for the identification of forensically relevant body fluids from degraded samples
基于 16S rRNA 基因测序的探索细菌 DNA 标记,用于从降解样品中鉴定法医相关体液
  • 批准号:
    21K21033
  • 财政年份:
    2021
  • 资助金额:
    $ 17.57万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Dirty Linen: the forensic soft matter science of body fluids on fabric
脏亚麻布:织物上体液的法医软物质科学
  • 批准号:
    2515837
  • 财政年份:
    2020
  • 资助金额:
    $ 17.57万
  • 项目类别:
    Studentship
Development of radiotherapy combined with a new diagnostic marker for body fluids that enables ultra-minimally invasiveness
开发出与新型体液诊断标志物相结合的放射疗法,可实现超微创
  • 批准号:
    19K17140
  • 财政年份:
    2019
  • 资助金额:
    $ 17.57万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Identification of circulating microRNA in body fluids associated with growth and rupture of cerebral aneurysm
体液中与脑动脉瘤生长和破裂相关的循环 microRNA 的鉴定
  • 批准号:
    19K18439
  • 财政年份:
    2019
  • 资助金额:
    $ 17.57万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of a comprehensive procedure for determination of multiple body fluids by multiplex reverse transcription-PCR
开发通过多重逆转录 PCR 测定多种体液的综合程序
  • 批准号:
    18K10138
  • 财政年份:
    2018
  • 资助金额:
    $ 17.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of chemical exposure effects in human mothers and children through metabolomic analysis of body fluids and feces
通过体液和粪便的代谢组学分析分析人类母亲和儿童的化学暴露影响
  • 批准号:
    18K18199
  • 财政年份:
    2018
  • 资助金额:
    $ 17.57万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Accurate measurement of natural toxins in body fluids using deuterated standards and search of specific markers for the rapid diagnosis
使用氘化标准品准确测量体液中的天然毒素并搜索特定标记物以进行快速诊断
  • 批准号:
    18H03064
  • 财政年份:
    2018
  • 资助金额:
    $ 17.57万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了